Clinical Trial Update: Daunorubicin & Cytarabine +/- Zosuquidar inTreating Older Patients With Newly Diagnosed Acute Myeloid Leukemia or Refractory Anemia [Phase 3]

View source ↗

Summary

A Phase 3 trial evaluating daunorubicin and cytarabine with or without zosuquidar in older patients with newly diagnosed acute myeloid leukemia or refractory an…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Acute Myeloid Leukemia
• Myelodysplastic Syndromes

Drugs mentioned

• CYTARABINE (CYTARABINE)
• Daunorubicin (daunorubicin)
• Zosuquidar (zosuquidar)

Snippet

Sponsor: Eastern Cooperative Oncology Group | Conditions: Leukemia, Myelodysplastic Syndromes | Phase 3 | Status: COMPLETED | Results posted: 2010-09-06